Clinical Trial of Programmable Implantable Insulin Pump For Type I Diabetes

Abstract

Insulin therapy with implantable pumps is effective and safe for periods up to 1.7 yr with a decreased risk of severe hypoglycemia than with intensive subcutaneous insulin therapy.